Eleven Tx

Eleven Therapeutics is on a mission to develop the next generation of nucleic acid therapeutics by
harnessing the power of state-of-the-art RNA biology, combinatorial chemistry, and A.I.,
transforming drug discovery and development into a programmable process. Our team consists of
world-class scientists and entrepreneurs, with a proven track record in breakthrough innovations
and therapeutic R&D. Our discovery engine integrates deep expertise in bio-engineering,
chemistry, genomics, and computer science. Our resultant pipeline is rapidly expanding, focusing
on a multitude of respiratory diseases, including antiviral prophylactics and treatments for non-
infectious diseases of substantial unmet medical need. Eleven Tx champions diversity and
inclusion, and spans multiple geographies, operating across Cambridge (UK), Tel-Aviv (Israel),
and Boston (US).